Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity is a research paper published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Naito Foundation
Grant: N/A
National Cancer Institute
Grant: P30-CA125123
National Cancer Institute
Grant: P50-CA186784-07
National Heart, Lung, and Blood Institute
Grant: T32HL092332
NCI NIH HHS
Grant: P50 CA186784
NCI NIH HHS
Grant: P30 CA125123
National Institutes of Health
Grant: 2T32HL092332-16
Training In Cell and Gene Therapy
National Institutes of Health
Grant: 3P50CA186784-10S1
Translational Research in Breast Cancer
National Institutes of Health
Grant: 3P30CA125123-09S3
Baylor College of Medicine Cancer Center
FWCI
3.46
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals